| Patient | Hippocrates |
|---|---|
| Date of birth | 1937-01-10 |
| Identifiers | MRN HR-AC005-SYN; SSN (made up) 000-05-8153 |
| Document date | 2026-03-02 |
| Author | Eleni Vasquez-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing care with a comprehensive geriatric assessment, after his annual wellness screening elsewhere noted slower walking and a near-fall: gait speed, Timed Up and Go, chair stands, balance, grip strength, MoCA, GDS-15, hearing, vision, nutrition and continence; frailty; a deprescribing review; bone health; what matters most to him; and a geriatric medicine consultation. [S]
Sodium: 139 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 1.08 mg/dL; Glucose: 92 mg/dL; Calcium: 9.3 mg/dL; eGFR (CKD-EPI 2021): 63 mL/min/1.73 m²; Hemoglobin: 13.6 g/dL; Platelets: 228 10*3/uL; Albumin: 4.1 g/dL; 25-hydroxyvitamin D: 24 ng/mL (low); TSH: 2.1 mIU/L; Grip strength, left hand: 22 kg; Grip strength, right hand: 24 kg; MoCA: 26; GDS-15: 2; KOOS JR (0 to 100; 100 is no knee difficulty): 62; Knee pain (0 to 10): 5. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-02 | Body height | 168 | cm | S |
| 2026-03-02 | Body weight | 64.2 | kg | S |
| 2026-03-02 | Body mass index (BMI) [Ratio] | 22.7 | kg/m2 | S |
| 2026-03-02 | Systolic blood pressure | 138 | mm[Hg] | S |
| 2026-03-02 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-03-02 | Heart rate | 68 | /min | S |
| 2026-03-02 | Respiratory rate | 16 | /min | S |
| 2026-03-02 | Body temperature | 36.5 | Cel | S |
| 2026-03-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-02 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-02 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-02 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-02 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-02 | Calcium [Mass/volume] in Serum or Plasma | 9.3 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-03-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 63 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-02 | Hemoglobin [Mass/volume] in Blood | 13.6 | g/dL | 13-17 g/dL | Normal | S |
| 2026-03-02 | Platelets [#/volume] in Blood by Automated count | 228 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-03-02 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-03-02 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 24 | ng/mL | Below 20 ng/mL deficient; 20 to 29 insufficient | Low | S |
| 2026-03-02 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 2026-03-02 | Grip strength Hand - left Dynamometer | 22 | kg | S | ||
| 2026-03-02 | Grip strength Hand - right Dynamometer | 24 | kg | S | ||
| 2026-03-02 | Total score [MoCA] | 26 | {score} | S | ||
| 2026-03-02 | Geriatric depression scale (GDS) short version total | 2 | {score} | S | ||
| 2026-03-02 | Total interval score [KOOSJR] | 62 | {score} | S | ||
| 2026-03-02 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen sodium 220 mg oral tablet, one or two tablets most days for knee pain, bought over the counter, for about two years; stopped at intake (Beers 2023: avoid chronic use) | One or two tablets by mouth up to twice a day, self-directed | Oral route | 2024-03-01 to 2026-03-02 | stopped | S |
| Diphenhydramine 25 mg oral capsule at bedtime three or four nights a week for sleep, bought over the counter; stopped at intake (Beers 2023: strongly anticholinergic) | One capsule at bedtime as needed, self-directed | Oral route | 2025-09-01 to 2026-03-02 | stopped | S |
| Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee pain, no more than 3,000 mg in a day | One to two tablets by mouth every eight hours as needed; no more than six tablets a day | Oral route | 2026-03-02 | active | S |
| Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily | One tablet by mouth daily | Oral route | 2026-03-02 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Slower walking, knee pain on stairs and one near-fall in the past six months, found on the comprehensive geriatric assessment at intake: gait speed 0.78 m/s, Timed Up and Go 13.8 seconds, unable to hold a tandem stance for 10 seconds, grip 24 kg; cause under evaluation with a geriatric medicine consultation | active | confirmed | R26.81 | S — Synthetic presenting problem of normal aging found on a comprehensive geriatric assessment; superseded at the consultation, when knee osteoarthritis with reduced leg strength and balance was diagnosed. |
| Potentially inappropriate over-the-counter medicines (Beers 2023): naproxen most days for about two years and diphenhydramine for sleep three or four nights a week; both stopped at intake | active | confirmed | Z79.1 | S — Synthetic medication history found on the deprescribing review. |